UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 33

Sortiert nach

Secukinumab in the Treatment of Noninfectious Uveitis: Results of Three Randomized, Controlled Clinical Trials

Ophthalmology (Rochester, Minn.), 2013-04, Vol.120 (4), p.777-787

2013

Link zum Volltext

Verfügbarkeit prüfen

Treatment patterns for retinal diseases in patients newly-treated with anti-VEGF agents: A retrospective analysis of claims data from the Japan Medical Data Center database

Japanese journal of ophthalmology, 2021-03, Vol.65 (2), p.215-226

2021

Link zum Volltext

Verfügbarkeit prüfen

Ranibizumab 0.5 mg treat-and-extend regimen for diabetic macular oedema: the RETAIN study

British journal of ophthalmology, 2016-06, Vol.100 (6), p.787-795

2016

Link zum Volltext

Verfügbarkeit prüfen

Famotidine for the prevention of peptic ulcers and oesophagitis in patients taking low-dose aspirin (FAMOUS): a phase III, randomised, double-blind, placebo-controlled trial

The Lancet (British edition), 2009-07, Vol.374 (9684), p.119-125

2009

Link zum Volltext

Verfügbarkeit prüfen

How do patients with secondary progressive multiple sclerosis enrolled in the EXPAND randomized controlled trial compare with those seen in German clinical practice in the NeuroTransData multiple sclerosis registry?

Journal of central nervous system disease, 2022-07, Vol.14, p.117957352211159-11795735221115912

2022

Link zum Volltext

Verfügbarkeit prüfen

Efficacy of anti-VEGF and laser photocoagulation in the treatment of visual impairment due to diabetic macular edema: a systematic review and network meta-analysis

PloS one, 2014-07, Vol.9 (7), p.e102309

2014

Link zum Volltext

Verfügbarkeit prüfen

Treat and Extend Treatment Interval Patterns with Anti-VEGF Therapy in nAMD Patients

Vision (Basel), 2019-08, Vol.3 (3), p.41

2019

Link zum Volltext

Verfügbarkeit prüfen

The impact of healthcare systems on the clinical diagnosis and disease-modifying treatment usage in relapse-onset multiple sclerosis: a real-world perspective in five registries across Europe

Therapeutic advances in neurological disorders, 2023-01, Vol.16, p.17562864231198963-17562864231198963

2023

Link zum Volltext

Verfügbarkeit prüfen

Early life socioeconomic adversity is associated in adult life with chronic inflammation, carotid atherosclerosis, poorer lung function and decreased cognitive performance: a cross-sectional, population-based study

BMC public health, 2011-01, Vol.11 (1), p.42-42, Article 42

2011

Link zum Volltext

Verfügbarkeit prüfen

PB2552: VAYHIA: A RANDOMIZED, DOUBLE‐BLIND, PHASE III TRIAL TO ASSESS THE EFFICACY AND SAFETY OF IANALUMAB VS PLACEBO IN PATIENTS WITH WARM AUTOIMMUNE HEMOLYTIC ANEMIA THAT FAILED ≥1 LINE OF TREATMENT

HemaSphere, 2023-08, Vol.7 (S3), p.e28542f2-n/a

2023

Link zum Volltext

Verfügbarkeit prüfen

Proportion and characteristics of secondary progressive multiple sclerosis in five European registries using objective classifiers

Multiple sclerosis journal - experimental, translational and clinical, 2023-01, Vol.9 (1), p.20552173231153557-20552173231153557

2023

Link zum Volltext

Verfügbarkeit prüfen

The economic and humanistic burden of patients in receipt of current available therapies for nAMD

Journal of comparative effectiveness research, 2018-11, Vol.7 (11), p.1125-1132

2018

Link zum Volltext

Verfügbarkeit prüfen

Reduced glomerular filtration rate and its association with clinical outcome in older patients at risk of vascular events: secondary analysis

PLoS medicine, 2009-01, Vol.6 (1), p.e16

2009

Link zum Volltext

Verfügbarkeit prüfen

Red cell distribution width has incremental prognostic value to B-type natriuretic peptide in acute heart failure

European journal of heart failure, 2009-12, Vol.11 (12), p.1152-1154

2009

Link zum Volltext

Verfügbarkeit prüfen

Psychological, social and biological determinants of ill health (pSoBid): study protocol of a population-based study

BMC public health, 2008-04, Vol.8 (1), p.126-126, Article 126

2008

Link zum Volltext

Verfügbarkeit prüfen

SIERRA-AMD: A Retrospective, Real-World Evidence Study of Patients with Neovascular Age-Related Macular Degeneration in the United States

Ophthalmology retina, 2020-02, Vol.4 (2), p.122-133

2020

Link zum Volltext

Verfügbarkeit prüfen

Validation of Magnetic Resonance Myocardial Perfusion Imaging With Fractional Flow Reserve for the Detection of Significant Coronary Heart Disease

Circulation (New York, N.Y.), 2009-12, Vol.120 (22), p.2207-2213

2009

Link zum Volltext

Verfügbarkeit prüfen

Comparative efficacy and safety of approved treatments for macular oedema secondary to branch retinal vein occlusion: a network meta-analysis

BMJ open, 2015-06, Vol.5 (6), p.e007527-e007527

2015

Link zum Volltext

Verfügbarkeit prüfen

Dispensing Patterns of Ranibizumab and Aflibercept for the Treatment of Neovascular Age-Related Macular Degeneration: A Retrospective Cohort Study in Australia

Advances in therapy, 2017-12, Vol.34 (12), p.2585-2600

2017

Link zum Volltext

Verfügbarkeit prüfen

P1‐607: INSIGHTS TO MODEL ALZHEIMER'S PROGRESSION IN REAL LIFE (IMAP): RATIONALE, OBJECTIVE, AND METHODOLOGY

Alzheimer's & dementia, 2018-07, Vol.14 (7S_Part_10), p.P572-P572

2018

Link zum Volltext

Verfügbarkeit prüfen

INSIGHTS TO MODEL ALZHEIMER’S PROGRESSION IN REAL LIFE (IMAP): RATIONALE, OBJECTIVE, AND METHODOLOGY

Alzheimer's & dementia, 2018-07, Vol.14 (7), p.P572-P572

2018

Link zum Volltext

Verfügbarkeit prüfen

ASSESSING CLINICAL MEANINGFULNESS OF OUTCOMES IN THE ALZHEIMER’S PREVENTION INITIATIVE GENERATION PROGRAM

Alzheimer's & dementia, 2019-07, Vol.15 (7), p.P520-P521

2019

Link zum Volltext

Verfügbarkeit prüfen

F2‐03‐04: ASSESSING CLINICAL MEANINGFULNESS OF OUTCOMES IN THE ALZHEIMER'S PREVENTION INITIATIVE GENERATION PROGRAM

Alzheimer's & dementia, 2019-07, Vol.15 (7S_Part_10), p.P520-P521

2019

Link zum Volltext

Verfügbarkeit prüfen

Effectiveness of Continued Ranibizumab Therapy in Neovascular Age-Related Macular Degeneration versus Switch to Aflibercept: Real World Evidence

Ophthalmology retina, 2019-01, Vol.3 (1), p.8-15.e1

2019

Link zum Volltext

Verfügbarkeit prüfen

25-Hydroxyvitamin D is lower in deprived groups, but is not associated with carotid intima media thickness or plaques: Results from pSoBid

Atherosclerosis, 2012-08, Vol.223 (2), p.437-441

2012

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 33

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(33)
Mit Volltextzugriff
(31)

Publikationsform

Artikel
(33)

Sprache

Englisch
(33)
Japanisch
(5)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Secukinumab in the Treatment of Noninfectious Uveitis: Results of Three Randomized, Controlled Clinical Trials

Treatment patterns for retinal diseases in patients newly-treated with anti-VEGF agents: A retrospective analysis of claims data from the Japan Medical Data Center database

Ranibizumab 0.5 mg treat-and-extend regimen for diabetic macular oedema: the RETAIN study

Famotidine for the prevention of peptic ulcers and oesophagitis in patients taking low-dose aspirin (FAMOUS): a phase III, randomised, double-blind, placebo-controlled trial

How do patients with secondary progressive multiple sclerosis enrolled in the EXPAND randomized controlled trial compare with those seen in German clinical practice in the NeuroTransData multiple sclerosis registry?

Efficacy of anti-VEGF and laser photocoagulation in the treatment of visual impairment due to diabetic macular edema: a systematic review and network meta-analysis

Treat and Extend Treatment Interval Patterns with Anti-VEGF Therapy in nAMD Patients

The impact of healthcare systems on the clinical diagnosis and disease-modifying treatment usage in relapse-onset multiple sclerosis: a real-world perspective in five registries across Europe

Early life socioeconomic adversity is associated in adult life with chronic inflammation, carotid atherosclerosis, poorer lung function and decreased cognitive performance: a cross-sectional, population-based study

PB2552: VAYHIA: A RANDOMIZED, DOUBLE‐BLIND, PHASE III TRIAL TO ASSESS THE EFFICACY AND SAFETY OF IANALUMAB VS PLACEBO IN PATIENTS WITH WARM AUTOIMMUNE HEMOLYTIC ANEMIA THAT FAILED ≥1 LINE OF TREATMENT

Proportion and characteristics of secondary progressive multiple sclerosis in five European registries using objective classifiers

The economic and humanistic burden of patients in receipt of current available therapies for nAMD

Reduced glomerular filtration rate and its association with clinical outcome in older patients at risk of vascular events: secondary analysis

Red cell distribution width has incremental prognostic value to B-type natriuretic peptide in acute heart failure

Psychological, social and biological determinants of ill health (pSoBid): study protocol of a population-based study

SIERRA-AMD: A Retrospective, Real-World Evidence Study of Patients with Neovascular Age-Related Macular Degeneration in the United States

Validation of Magnetic Resonance Myocardial Perfusion Imaging With Fractional Flow Reserve for the Detection of Significant Coronary Heart Disease

Comparative efficacy and safety of approved treatments for macular oedema secondary to branch retinal vein occlusion: a network meta-analysis

Dispensing Patterns of Ranibizumab and Aflibercept for the Treatment of Neovascular Age-Related Macular Degeneration: A Retrospective Cohort Study in Australia

P1‐607: INSIGHTS TO MODEL ALZHEIMER'S PROGRESSION IN REAL LIFE (IMAP): RATIONALE, OBJECTIVE, AND METHODOLOGY

INSIGHTS TO MODEL ALZHEIMER’S PROGRESSION IN REAL LIFE (IMAP): RATIONALE, OBJECTIVE, AND METHODOLOGY

ASSESSING CLINICAL MEANINGFULNESS OF OUTCOMES IN THE ALZHEIMER’S PREVENTION INITIATIVE GENERATION PROGRAM

F2‐03‐04: ASSESSING CLINICAL MEANINGFULNESS OF OUTCOMES IN THE ALZHEIMER'S PREVENTION INITIATIVE GENERATION PROGRAM

Effectiveness of Continued Ranibizumab Therapy in Neovascular Age-Related Macular Degeneration versus Switch to Aflibercept: Real World Evidence

25-Hydroxyvitamin D is lower in deprived groups, but is not associated with carotid intima media thickness or plaques: Results from pSoBid

Suchergebnisse filtern